These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23192154)

  • 1. B-cell depletion improves islet allograft survival with anti-CD45RB.
    Lee KM; Yeh H; Zhao G; Wei L; O'Connor M; Stott RT; Soohoo J; Dunussi K; Fiorina P; Deng S; Markmann JF; Kim JI
    Cell Transplant; 2014 Jan; 23(1):51-8. PubMed ID: 23192154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunosufficient murine model for the study of human islets.
    Zhao G; Moore DJ; Kim JI; Lee KM; O'Connor M; Yang M; Marshall AF; Lei J; Schuetz C; Markmann JF; Deng S
    Xenotransplantation; 2014; 21(6):567-73. PubMed ID: 25041432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses.
    Carvello M; Petrelli A; Vergani A; Lee KM; Tezza S; Chin M; Orsenigo E; Staudacher C; Secchi A; Dunussi-Joannopoulos K; Sayegh MH; Markmann JF; Fiorina P
    Diabetes; 2012 Jan; 61(1):155-65. PubMed ID: 22076927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB.
    Rayat GR; Gill RG
    Diabetes; 2005 Feb; 54(2):443-51. PubMed ID: 15677502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression.
    Ariyan C; Salvalaggio P; Fecteau S; Deng S; Rogozinski L; Mandelbrot D; Sharpe A; Sayegh MH; Basadonna GP; Rothstein DM
    J Immunol; 2003 Dec; 171(11):5673-7. PubMed ID: 14634073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo induction of regulatory T cells by anti-CD45RB antibody causes transferable tolerance to discordant human xenogenic islets.
    Zhang Y; Yang M; Jia G; Deng S; Lei J; Markmann J; Zhao G
    Xenotransplantation; 2022 Nov; 29(6):e12778. PubMed ID: 36125404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF.
    Parsons RF; Yu M; Vivek K; Zekavat G; Rostami SY; Ziaie AS; Luo Y; Koeberlein B; Redfield RR; Ward CD; Migone TS; Cancro MP; Naji A; Noorchashm H
    Transplantation; 2012 Apr; 93(7):676-85. PubMed ID: 22262127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models.
    Rothstein DM; Livak MF; Kishimoto K; Ariyan C; Qian HY; Fecteau S; Sho M; Deng S; Zheng XX; Sayegh MH; Basadonna GP
    J Immunol; 2001 Jan; 166(1):322-9. PubMed ID: 11123308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance.
    Huang X; Moore DJ; Mohiuddin M; Lian MM; Kim JI; Sonawane S; Wang J; Gu Y; Yeh H; Markmann JF; Deng S
    Transplantation; 2008 Mar; 85(5):675-80. PubMed ID: 18337659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Subsets of IL-10-Producing Regulatory B Cells in the Course of Tolerance Induction and Maintenance in Islet Allotransplantation.
    Li S; Li X; Yang M; Wei L; Wei L; Deng S; Zhao G
    Transplant Proc; 2018 Dec; 50(10):3900-3905. PubMed ID: 30577284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD45RB treatment prolongs islet allograft survival in mice.
    Auersvald LA; Rothstein DM; Oliveira SC; Khuong CQ; Basadonna GP
    Transplant Proc; 1997; 29(1-2):771. PubMed ID: 9123520
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies.
    Auersvald LA; Rothstein DM; Oliveira SC; Khuong CQ; Onodera H; Lazarovits AI; Basadonna GP
    Transplantation; 1997 May; 63(9):1355-8. PubMed ID: 9158033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.
    Yin N; Zhang N; Xu J; Shi Q; Ding Y; Bromberg JS
    Transplantation; 2011 Jul; 92(1):25-30. PubMed ID: 21508896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD45RB and donor-specific spleen cells transfusion inhibition allograft skin rejection mediated by memory T cells.
    Jian YQ; Ye J; Qi H; Deng CY; Deng SP; Li FR
    Immunol Cell Biol; 2017 Feb; 95(2):189-197. PubMed ID: 27616751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
    Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
    Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD45RB antibody deters xenograft rejection by modulating T cell priming and homing.
    Sutherland RM; McKenzie BS; Zhan Y; Corbett AJ; Fox-Marsh A; Georgiou HM; Harrison LC; Lew AM
    Int Immunol; 2002 Aug; 14(8):953-62. PubMed ID: 12147632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo.
    Salvalaggio PR; Camirand G; Ariyan CE; Deng S; Rogozinski L; Basadonna GP; Rothstein DM
    J Immunol; 2006 Feb; 176(4):2292-8. PubMed ID: 16455985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy.
    Basadonna GP; Auersvald L; Khuong CQ; Zheng XX; Kashio N; Zekzer D; Minozzo M; Qian H; Visser L; Diepstra A; Lazarovits AI; Poppema S; Strom TB; Rothstein DM
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3821-6. PubMed ID: 9520451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.